查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1941510

血糖值监测设备市场规模、份额和趋势分析报告：按产品、性别、最终用途、地区和细分市场预测（2026-2033 年）

Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Self-Monitoring Devices, Continuous Glucose Monitoring Devices), By Connectivity, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 250 Pages | 商品交期: 2-10个工作天内

价格

血糖值监测设备市场概览

2025年全球血糖值监测市场规模估计为155.3亿美元，预计2033年将达到301.8亿美元。

预计从 2026 年到 2033 年，该市场将以 8.8% 的复合年增长率成长。这个市场的主要影响因素是糖尿病盛行率的上升以及老年人口的成长，老年人更容易患上糖尿病等疾病。

此外，人们对糖尿病预防措施的意识提升以及新产品的推出也推动了市场成长。糖尿病是一种全球流行且日益严重的疾病，其特征是胰臟无法有效产生胰岛素，导致血糖水平升高。血糖值监测技术不仅能够实现即时干预，也是对患者进行糖尿病及其有效管理教育的重要工具。

预计在预测期内，全球糖尿病盛行率的不断上升将推动强劲的市场需求。根据健康指标评估实验室（Health Metrics Assessment Lab，2023年6月）的数据显示，目前全球有超过5亿人患有糖尿病，影响所有人。糖尿病的全球盛行率为6.1%，名列十大死因与致残原因。北非和中东地区的盛行率最高，达9.3%，预计2050年将上升至16.8%。拉丁美洲和加勒比海地区的盛行率预计将上升至11.3%。

此外，人们对糖尿病预防措施的认识不断提高以及新产品的推出正在推动市场成长。糖尿病是一种由于胰臟无法有效产生胰岛素而导致血糖值升高的疾病，是一个日益严重的全球性问题。根据国际糖尿病联盟（IDF）统计，2021年全球糖尿病确诊患者人数将达到约5.37亿，预计2030年将达到6.43亿，到2045年将达到7.83亿。

血糖值监测设备在帮助糖尿病患者方面发挥着多种重要作用。首先，它们使患者和医护人员能够了解血糖值的升降情况，从而及时调整治疗方案。此功能有助于快速辨识急性低血糖和高血糖，保障患者的健康。此外，这些设备有助于患者进行自我管理，从而更有效地控製糖尿病。而且，血糖值监测设备所采用的技术不仅有助于即时干预，还能作为糖尿病及其有效管理的重要教育工具。

糖尿病的盛行率往往老龄化增加而增加，老年人罹患糖尿病及其併发症的风险更高。随着老年人口的增长，糖尿病高风险族群的数量也在增加，从而推动了对血糖值监测设备的需求。例如，根据美国国家糖尿病统计报告，2021年美国有2720万65岁及以上的老年人处于糖尿病前期。研究表明，即时连续血糖值监测（CGM）设备对65岁及以上的第2型糖尿病患者有效且安全。与背景血糖值监测（BGM）相比，使用CGM的65岁及以上参与者的糖化血红蛋白（HbA1c）水平显着改善，血糖值控制也得到改善。这些结果凸显了CGM设备作为有效管理老年人糖尿病的重要工具的潜在价值。

新冠感染疾病对市场产生了重大影响。它凸显了医疗保健方面的不平等以及技术的重要性，尤其是背景血糖监测仪（BGM）。监管政策的调整（例如，放宽持续血糖值监测仪（rtCGM）的使用显着改善了血糖控制，延长了血糖在目标范围内的时间并降低了血糖波动，从而极大地促进了整体市场成长。

目录

第一章调查方法和范围

第二章血糖值监测设备市场：执行摘要

  • 市场概览
  • 产品、连接方式和最终用途概述
  • 竞争格局概述

第三章血糖值监测设备市场变数、趋势与范围

  • 市场区隔和范围
  • 市场谱系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
  • 市场驱动因素分析
    • 世界人口老化问题日益严重
    • 糖尿病患者人数不断增加
    • 提高对糖尿病预防保健的认识
  • 市场限制因素分析
    • 设备高成本
  • 血糖值监测设备市场分析工具
    • 产业分析：波特五力模型
    • PESTLE分析
    • 定价分析

第四章血糖值测量设备：产品分类、估算与趋势分析

  • 全球血糖值监测设备市场：产品差异分析
  • 全球血糖值监测设备市场规模及趋势分析（依产品分类，2021-2033 年）
  • 自测量装置
    • 2021-2033年市场估算与预测
    • 血糖仪
    • 测试条
    • 《采血针》
  • 连续血糖值监测设备
    • 2021-2033年市场估算与预测
    • 感应器
    • 发送器和接收器
    • 胰岛素帮浦

第五章血糖值监测设备：连结性别、估算与趋势分析

  • 全球血糖值监测设备市场：连接方式差异分析
  • 全球血糖值监测设备市场规模及趋势分析（按连接类型划分，2021-2033 年）
  • 支援蓝牙的设备
  • 支援 Wi-Fi 的设备
  • 支援近距离场通讯 (NFC) 的设备
  • USB连接装置

第六章血糖值监测设备：依最终用途分類的估算与趋势分析

  • 全球血糖值监测设备市场：终端用途差异分析
  • 全球血糖值监测设备市场规模及趋势分析（依最终用途划分，2021-2033 年）
  • 医院
  • 居家医疗
  • 诊断中心

第七章 区域业务分析

  • 区域市场概览
  • 全球市场概览（按地区划分）
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商概况
    • 主要经销商和通路伙伴
    • 主要客户
    • 主要企业市占率分析，2025 年
Product Code: GVR-3-68038-688-2

Blood Glucose Monitoring Devices Market Summary

The global blood glucose monitoring devices market size was estimated at USD 15.53 billion in 2025 and is projected to reach USD 30.18 billion by 2033, growing at a CAGR of 8.8% from 2026 to 2033. The market is primarily influenced by the growing prevalence of diabetes and growing elderly population susceptible to conditions such as diabetes.

In addition, market growth is driven by rising awareness of preventive measures for diabetes and the introduction of new products. Diabetes, a widespread and increasing global concern, is characterized by the pancreas' inability to efficiently produce insulin, leading to elevated blood glucose levels. Moreover, the technology associated with blood glucose monitoring not only aids immediate intervention but also serves as a valuable tool for patient education on diabetes and its effective management.

The rising global prevalence of diabetes is anticipated to drive strong market demand during the forecast period. According to the Institute for Health Metrics and Evaluation (June 2023), over 500 million people worldwide currently live with diabetes, impacting individuals across all demographics. With a global prevalence of 6.1%, diabetes ranks among the top 10 causes of death and disability. North Africa and the Middle East lead with a 9.3% prevalence, which is expected to increase to 16.8% by 2050. In Latin America and the Caribbean, the prevalence is projected to rise to 11.3%.

In addition, market growth is driven by rising awareness of preventive measures for diabetes and the introduction of new products. Diabetes, a widespread and growing global concern, is characterized by the pancreas' inability to efficiently produce insulin, leading to elevated blood glucose levels. According to the International Diabetes Federation, approximately 537 million individuals were diagnosed with diabetes in 2021, and projections indicate an anticipated rise to 643 million by 2030 and 783 million by 2045.

Blood glucose monitoring (BGM) devices play a crucial role in supporting individuals with diabetes in numerous ways. Initially, they empower both patients and healthcare professionals to identify elevated or reduced blood glucose levels, enabling timely adjustments to treatment plans. This capability serves as a protective measure by promptly confirming acute hypoglycemia or hyperglycemia, ensuring the well-being of patients. In addition, these devices enhance self-care practices, offering individuals greater control over their diabetes management. Moreover, the technology associated with blood glucose monitoring not only aids in immediate intervention but also serves as a valuable tool for patient education on diabetes and its effective management.

The prevalence of diabetes tends to increase with age, and older adults are more susceptible to developing diabetes or experiencing complications related to the disease. As the geriatric population increases, so does the pool of individuals at risk of diabetes, creating a greater demand for blood glucose monitoring devices. For instance, based on the National Diabetes Statistics Report, in 2021, in the U.S. 27.2 million adults aged 65 years or older had prediabetes. Studies have shown that real-time continuous glucose monitoring (CGM) is effective and safe in adults aged 65 years and older with type 2 diabetes. Participants aged 65 years and above showed a significant improvement in their hemoglobin A1c (HbA1c) levels, which indicates better control of blood glucose levels when using CGM compared to blood glucose monitoring (BGM). These results underscore the potential value of CGM devices as a beneficial tool for effectively managing diabetes in the elderly population.

The COVID-19 pandemic has significantly impacted the market. The pandemic highlighted healthcare disparities and technological importance, including BGM devices. Regulatory changes, such as relaxed requirements for obtaining continuous glucose monitoring (CGM), have increased access to these devices, particularly benefiting those who can benefit from the technology. Furthermore, the use of real-time continuous glucose monitoring (rtCGM) was observed during lockdowns for improved glycemic control, reducing the time in range & glucose variability, thereby significantly boosting the overall market growth.

Global Blood Glucose Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global blood glucose monitoring devices market report on the basis of product, connectivity, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Self-Monitoring Devices
    • Blood Glucose Meters
    • Traditional BGMs
    • Smart BGMs
    • Testing Strips
    • Lancets
  • Continuous Glucose Monitoring (CGM) Devices
    • Sensors
    • Transmitter and Receiver
    • Insulin Pumps
    • Traditional Insulin Pumps
    • Smart Insulin Pumps
  • Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
  • Bluetooth-Enabled Devices
  • Wi-Fi-Enabled Devices
  • Near Field Communication (NFC) Devices
  • USB Connectivity Devices
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Home Care
  • Diagnostic Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Connectivity Segment
    • 1.2.3. End-use Segment
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Objectives
    • 1.5.1. Objective - 1
    • 1.5.2. Objective - 2
  • 1.6. Research Methodology
  • 1.7. Information Procurement
    • 1.7.1. Purchased Database
    • 1.7.2. GVR's Internal Database
    • 1.7.3. Secondary Sources
    • 1.7.4. Primary Research
  • 1.8. Information or Data Analysis
    • 1.8.1. Data Analysis Models
  • 1.9. Market Formulation & Validation
  • 1.10. Model Details
    • 1.10.1. Commodity Flow Analysis
  • 1.11. List of Primary Sources
  • 1.12. List of Abbreviations

Chapter 2. Blood Glucose Monitoring Devices Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Products, Connectivity, and End Use Snapshots
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Blood Glucose Monitoring Devices Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising geriatric population worldwide
    • 3.4.2. Increasing number of diabetes patients
    • 3.4.3. Increasing awareness about diabetes preventive care
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of devices
  • 3.6. Blood Glucose Monitoring Devices Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier Power
      • 3.6.1.2. Buyer Power
      • 3.6.1.3. Substitution Threat
      • 3.6.1.4. Threat Of New Entrant
      • 3.6.1.5. Competitive Rivalry
    • 3.6.2. PESTLE Analysis
      • 3.6.2.1. Political Landscape
      • 3.6.2.2. Technological Landscape
      • 3.6.2.3. Economic Landscape
    • 3.6.3. Pricing Analysis

Chapter 4. Blood Glucose Monitoring Devices: Product Estimates & Trend Analysis

  • 4.1. Global Blood Glucose Monitoring Market: Product Segment Dashboard
  • 4.2. Global Blood Glucose Monitoring Devices Market by Product Outlook
  • 4.3. Global Blood Glucose Monitoring Devices Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
  • 4.4. Self-Monitoring Devices
    • 4.4.1. Market Estimates and Forecasts 2021 to 2033 (USD Million)
    • 4.4.2. Blood Glucose Meter
      • 4.4.2.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
      • 4.4.2.2. Traditional BGMs
        • 4.4.2.2.1 Market Estimates and Forecasts 2021 - 2033 (USD Million)
      • 4.4.2.3. Smart BGMs
        • 4.4.2.3.1 Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 4.4.3. Testing Strips
      • 4.4.3.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 4.4.4. Lancets
      • 4.4.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 4.5. Continuous Blood Glucose Monitoring Devices
    • 4.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 4.5.2. Sensors
      • 4.5.2.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 4.5.3. Transmitter & Receiver
      • 4.5.3.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 4.5.4. Insulin Pumps
      • 4.5.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
      • 4.5.4.2. Traditional Insulin Pumps
        • 4.5.4.2.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
      • 4.5.4.3. Smart Insulin Pumps
        • 4.5.4.3.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 5. Blood Glucose Monitoring Devices: Connectivity Estimates & Trend Analysis

  • 5.1. Global Blood Glucose Monitoring Market: Connectivity Segment Dashboard
  • 5.2. Global Blood Glucose Monitoring Market: Connectivity Movement Analysis
  • 5.3. Global Blood Glucose Monitoring Market Size & Trend Analysis, by Connectivity, 2021 - 2033 (USD Million)
  • 5.4. Bluetooth-Enabled Devices
    • 5.4.1 Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 5.5 Wi-Fi-Enabled Devices
    • 5.5.1 Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 5.6 Near Field Communication (NFC) Devices
    • 5.6.1 Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 5.7 USB Connectivity Devices
    • 5.7.1 Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 6. Blood Glucose Monitoring Devices: End Use Estimates & Trend Analysis

  • 6.1. Global Blood Glucose Monitoring Market: End Use Segment Dashboard
  • 6.2. Global Blood Glucose Monitoring Market: End Use Movement Analysis
  • 6.3. Global Blood Glucose Monitoring Market Size & Trend Analysis, by End Use, 2021 - 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 6.5. Homecare
    • 6.5.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 6.6. Diagnostics Centers
    • 6.6.1. Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Marker Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Competitive Scenario
      • 7.4.1.3. Regulatory Framework
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. Canada Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Competitive Scenario
      • 7.5.1.3. Regulatory Framework
      • 7.5.1.4. UK Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Germany Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.3. Spain
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Spain Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. France Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Italy Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Norway Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Competitive Scenario
      • 7.6.1.3. Regulatory Framework
      • 7.6.1.4. Japan Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. China Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. India Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.6.4. South Korea
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. South Korea Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Thailand Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Australia Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Competitive Scenario
      • 7.7.1.3. Regulatory Framework
      • 7.7.1.4. Brazil Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.7.2. Mexico
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Mexico Blood Glucose Monitoring Devices Market, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Argentina Market Estimates and Forecasts 2021 - 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Competitive Scenario
      • 7.8.1.3. Regulatory Framework
      • 7.8.1.4. South Africa Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Saudi Arabia Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. UAE Market Estimates and Forecasts 2021 - 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Kuwait Market Estimates and Forecasts 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company /Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List Of Key Distributors and Channel Partners
    • 8.3.2. Key Customers
    • 8.3.3. Key Company Market Share Analysis, 2025
      • 8.3.3.1. Abbott Laboratories
        • 8.3.3.1.1. Company overview
        • 8.3.3.1.2. Financial performance
        • 8.3.3.1.3. Product benchmarking
        • 8.3.3.1.4. Strategic initiatives
      • 8.3.3.2. Medtronic plc
        • 8.3.3.2.1. Company overview
        • 8.3.3.2.2. Financial performance
        • 8.3.3.2.3. Product benchmarking
        • 8.3.3.2.4. Strategic initiatives
      • 8.3.3.3. F. Hoffmann-La Roche Ltd
        • 8.3.3.3.1. Company overview
        • 8.3.3.3.2. Financial performance
        • 8.3.3.3.3. Product benchmarking
        • 8.3.3.3.4. Strategic initiatives
      • 8.3.3.4. Dexcom, Inc.
        • 8.3.3.4.1. Company overview
        • 8.3.3.4.2. Financial performance
        • 8.3.3.4.3. Product benchmarking
        • 8.3.3.4.4. Strategic initiatives
      • 8.3.3.5. Sanofi
        • 8.3.3.5.1. Company overview
        • 8.3.3.5.2. Financial performance
        • 8.3.3.5.3. Product benchmarking
        • 8.3.3.5.4. Strategic initiatives
      • 8.3.3.6. Novo Nordisk
        • 8.3.3.6.1. Company overview
        • 8.3.3.6.2. Financial performance
        • 8.3.3.6.3. Product benchmarking
        • 8.3.3.6.4. Strategic initiatives
      • 8.3.3.7. Insulet Corporation
        • 8.3.3.7.1. Company overview
        • 8.3.3.7.2. Financial performance
        • 8.3.3.7.3. Product benchmarking
        • 8.3.3.7.4. Strategic initiatives
      • 8.3.3.8. Ypsomed Holdings
        • 8.3.3.8.1. Company overview
        • 8.3.3.8.2. Financial performance
        • 8.3.3.8.3. Product benchmarking
        • 8.3.3.8.4. Strategic initiatives
      • 8.3.3.9. Glysens Incorporated
        • 8.3.3.9.1. Company overview
        • 8.3.3.9.2. Financial performance
        • 8.3.3.9.3. Product benchmarking
        • 8.3.3.9.4. Strategic initiatives
      • 8.3.3.10. Senseonics Holdings, Inc.
        • 8.3.3.10.1. Company overview
        • 8.3.3.10.2. Financial performance
        • 8.3.3.10.3. Product benchmarking
        • 8.3.3.10.4. Strategic initiatives
      • 8.3.3.11. GlucoRx Limited
        • 8.3.3.11.1. Company overview
        • 8.3.3.11.2. Financial performance
        • 8.3.3.11.3. Product benchmarking
        • 8.3.3.11.4. Strategic initiatives
      • 8.3.3.12. Zhejiang POCTech Co., Ltd
        • 8.3.3.12.1. Company overview
        • 8.3.3.12.2. Financial performance
        • 8.3.3.12.3. Product benchmarking
        • 8.3.3.12.4. Strategic initiatives
      • 8.3.3.13. i-SENS, Inc.
        • 8.3.3.13.1. Company overview
        • 8.3.3.13.2. Financial performance
        • 8.3.3.13.3. Product benchmarking
        • 8.3.3.13.4. Strategic initiatives
      • 8.3.3.14. Nemaura Medical Inc.
        • 8.3.3.14.1. Company overview
        • 8.3.3.14.2. Financial performance
        • 8.3.3.14.3. Product benchmarking
        • 8.3.3.14.4. Strategic initiatives
      • 8.3.3.15. Sinocare, Inc.
        • 8.3.3.15.1. Company overview
        • 8.3.3.15.2. Financial performance
        • 8.3.3.15.3. Product benchmarking
        • 8.3.3.15.4. Strategic initiatives
      • 8.3.3.16. Bionime
        • 8.3.3.16.1. Company overview
        • 8.3.3.16.2. Financial performance
        • 8.3.3.16.3. Product benchmarking
        • 8.3.3.16.4. Strategic initiatives
      • 8.3.3.17. AgaMatrix
        • 8.3.3.17.1. Company overview
        • 8.3.3.17.2. Financial performance
        • 8.3.3.17.3. Product benchmarking
        • 8.3.3.17.4. Strategic initiatives

List of Tables

  • Table 1. List of abbreviation
  • Table 2. North America Blood Glucose Monitoring Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 3. North America Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 4. North America Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 5. North America Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 6. U.S. Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 7. U.S. Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 8. U.S. Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 9. Canada Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 10. Canada Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 11. Canada Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 12. Europe Blood Glucose Monitoring Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 13. Europe Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 14. Europe Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 15. Europe Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 16. UK Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 17. UK Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 18. UK Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 19. Germany Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 20. Germany Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 21. Germany Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 22. France Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 23. France Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 24. France Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25. Italy Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 26. Italy Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 27. Italy Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 28. Spain Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 29. Spain Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 30. Spain Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 31. Sweden Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 32. Sweden Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 33. Sweden Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34. Norway Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 35. Norway Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 36. Norway Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 37. Denmark Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 38. Denmark Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 39. Denmark Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 40. Asia Pacific Blood Glucose Monitoring Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 41. Asia Pacific Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 42. Asia Pacific Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 43. Asia Pacific Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44. Japan Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 45. Japan Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 46. Japan Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 47. China Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 48. China Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 49. China Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50. India Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 51. India Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 52. India Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 53. Australia Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 54. Australia Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 55. Australia Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 56. South Korea Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 57. South Korea Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 58. South Korea Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 59. Thailand Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 60. Thailand Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 61. Thailand Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62. Latin America Blood Glucose Monitoring Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 63. Latin America Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 64. Latin America Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 65. Latin America Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 66. Brazil Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 67. Brazil Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 68. Brazil Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 69. Mexico Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 70. Mexico Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 71. Mexico Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 72. Argentina Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 73. Argentina Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 74. Argentina Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75. MEA Blood Glucose Monitoring Devices Market, Region, 2021 - 2033 (USD Million)
  • Table 76. MEA Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 77. MEA Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 78. MEA Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79. South Africa Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 80. South Africa Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 81. South Africa Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 82. Saudi Arabia Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 83. Saudi Arabia Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 84. Saudi Arabia Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 85. UAE Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 86. UAE Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 87. UAE Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 88. Kuwait Blood Glucose Monitoring Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 89. Kuwait Blood Glucose Monitoring Devices Market, By Connectivity, 2021 - 2033 (USD Million)
  • Table 90. Kuwait Blood Glucose Monitoring Devices Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews in North America
  • Fig. 5 Primary Interviews in Europe
  • Fig. 6 Primary Interviews in APAC
  • Fig. 7 Primary Interviews in Latin America
  • Fig. 8 Primary Interviews in MEA
  • Fig. 9 Market Research Approaches
  • Fig. 10 Value-Chain-Based Sizing & Forecasting
  • Fig. 11 QFD Modeling for Market Share Assessment
  • Fig. 12 Market Formulation & Validation
  • Fig. 13 Blood Glucose Monitoring Devices Market: Market Outlook
  • Fig. 14 Blood Glucose Monitoring Devices Competitive Insights
  • Fig. 15 Parent Market Outlook
  • Fig. 16 Related/Ancillary Market Outlook
  • Fig. 17 Penetration and Growth Prospect Mapping
  • Fig. 18 Industry Value Chain Analysis
  • Fig. 19 Blood Glucose Monitoring Devices Market Driver Impact
  • Fig. 20 Blood Glucose Monitoring Devices Market Restraint Impact
  • Fig. 21 Blood Glucose Monitoring Devices Market Strategic Initiatives Analysis
  • Fig. 22 Blood Glucose Monitoring Devices Market: Product Movement Analysis
  • Fig. 23 Blood Glucose Monitoring Devices Market: Product Outlook and Key Takeaways
  • Fig. 24 Self-Monitoring Devices Market Estimates and Forecast, 2021 - 2033
  • Fig. 25 Blood Glucose Meter Market Estimates and Forecast, 2021 - 2033
  • Fig. 26 Traditional BGMs Market Estimates and Forecast, 2021 - 2033
  • Fig. 27 Smart BGMs Market Estimates and Forecast, 2021 - 2033
  • Fig. 28 Strips Market Estimates and Forecast, 2021 - 2033
  • Fig. 29 Lancets Market Estimates and Forecast, 2021 - 2033
  • Fig. 30 Continuous monitoring devices Market Estimates and Forecast, 2021 - 2033
  • Fig. 31 Sensor Market Estimates and Forecast, 2021 - 2033
  • Fig. 32 Transmitter and Receiver Market Estimates and Forecast, 2021 - 2033
  • Fig. 33 Insulin pumps Market Estimates and Forecast, 2021 - 2033
  • Fig. 34 Traditional Insulin Pumps Market Estimates and Forecast, 2021 - 2033
  • Fig. 35 Smart Insulin Pumps Market Estimates and Forecast, 2021 - 2033
  • Fig. 36 Blood Glucose Monitoring Devices Market: Connectivity Movement Analysis
  • Fig. 37 Blood Glucose Monitoring Devices Market: Connectivity Outlook and Key Takeaways
  • Fig. 38 Bluetooth-Enabled Devices Market Estimates and Forecast, 2021 - 2033
  • Fig. 39 Wi-Fi-Enabled Devices Market Estimates and Forecast, 2021 - 2033
  • Fig. 40 Near Field Communication (NFC) Devices Market Estimates and Forecast, 2021 - 2033
  • Fig. 41 USB Connectivity Devices Market Estimates and Forecast, 2021 - 2033
  • Fig. 42 Blood Glucose Monitoring Devices Market: End Use Movement Analysis
  • Fig. 43 Blood Glucose Monitoring Devices Market: End Use Outlook and Key Takeaways
  • Fig. 44 Hospitals Market Estimates and Forecasts, 2021 - 2033
  • Fig. 45 Home Care Market Estimates and Forecasts, 2021 - 2033
  • Fig. 46 Diagnostic Centers Market Estimates and Forecasts, 2021 - 2033
  • Fig. 47 Global Blood Glucose Monitoring Devices Market: Regional Movement Analysis
  • Fig. 48 Global Blood Glucose Monitoring Devices Market: Regional Outlook and Key Takeaways
  • Fig. 49 North America Market Estimates and Forecasts, 2021 - 2033
  • Fig. 50 U.S. Market Estimates and Forecasts, 2021 - 2033
  • Fig. 51 Canada Market Estimates and Forecasts, 2021 - 2033
  • Fig. 52 Europe Market Estimates and Forecasts, 2021 - 2033
  • Fig. 53 UK Market Estimates and Forecasts, 2021 - 2033
  • Fig. 54 Germany Market Estimates and Forecasts, 2021 - 2033
  • Fig. 55 France Market Estimates and Forecasts, 2021 - 2033
  • Fig. 56 Italy Market Estimates and Forecasts, 2021 - 2033
  • Fig. 57 Spain Market Estimates and Forecasts, 2021 - 2033
  • Fig. 58 Denmark Market Estimates and Forecasts, 2021 - 2033
  • Fig. 59 Sweden Market Estimates and Forecasts, 2021 - 2033
  • Fig. 60 Norway Market Estimates and Forecasts, 2021 - 2033
  • Fig. 61 Asia Pacific Market Estimates and Forecasts, 2021 - 2033
  • Fig. 62 China Market Estimates and Forecasts, 2021 - 2033
  • Fig. 63 Japan Market Estimates and Forecasts, 2021 - 2033
  • Fig. 64 India Market Estimates and Forecasts, 2021 - 2033
  • Fig. 65 Thailand Market Estimates and Forecasts, 2021 - 2033
  • Fig. 66 South Korea Market Estimates and Forecasts, 2021 - 2033
  • Fig. 67 Australia Market Estimates and Forecasts, 2021 - 2033
  • Fig. 68 Latin America Market Estimates and Forecasts, 2021 - 2033
  • Fig. 69 Brazil Market Estimates and Forecasts, 2021 - 2033
  • Fig. 70 Mexico Market Estimates and Forecasts, 2021 - 2033
  • Fig. 71 Argentina Market Estimates and Forecasts, 2021 - 2033
  • Fig. 72 Middle East and Africa Market Estimates and Forecasts, 2021 - 2033
  • Fig. 73 South Africa Market Estimates and Forecasts, 2021 - 2033
  • Fig. 74 Saudi Arabia Market Estimates and Forecasts, 2021 - 2033
  • Fig. 75 UAE Market Estimates and Forecasts, 2021 - 2033
  • Fig. 76 Kuwait Market Estimates and Forecasts, 2021 - 2033
  • Fig. 77 Market Categorization
  • Fig. 78 Market Share of Key Market Players- Blood Glucose Monitoring Devices Market